Rab39B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RAB39B (RAB39B, Member RAS Oncogene Family) is a small GTPase involved in intracellular membrane trafficking. Mutations in RAB39B cause X-linked Parkinson's disease with associated intellectual disability and developmental delay. The gene encodes a ~235 amino acid protein that localizes to endolysosomal compartments.
RAB39B is a member of the Rab GTPase family:
- Endolysosomal trafficking: Regulates vesicular transport between endosomes and lysosomes
- Autophagosome maturation: Participates in autophagy pathway
- Synaptic function: Involved in synaptic vesicle trafficking and neurotransmitter release
- Lysosomal function: Regulates lysosomal positioning and function
- Mitochondrial dynamics: Influences mitochondrial distribution and quality control
- Active GTP-bound and inactive GDP-bound states
- Regulated by GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs)
- RAB39B GEF: RABGEF1 (Rabconnectin-3)
- RAB39B loss-of-function mutations cause X-linked PD with ID
- RAB39B p.W71X and p.G269R mutations identified
- Male patients present with:
- Early-onset Parkinsonism (age 12-30)
- Intellectual disability/developmental delay
- Speech impairment
- Often have macrocephaly
- RAB39B mutations cause nonsyndromic X-linked intellectual disability
- Heterozygous females may show mild cognitive impairment
- RAB39B mutations cause Waisman syndrome (X-linked Parkinsonism with ID)
- Characterized by early-onset movement disorder and developmental regression
RAB39B is expressed in:
- Brain: Substantia nigra, cerebral cortex, hippocampus, basal ganglia
- Neurons: Particularly in dopaminergic neurons
- Peripheral tissues: Heart, lung, liver, skeletal muscle
- RAB39B mutations cause X-linked Parkinsonism - Wilson GR et al., Am J Hum Genet 2014
- RAB39B regulates endolysosomal trafficking - Gong G et al., Autophagy 2019
- RAB39B deficiency in dopaminergic neurons - Zhang Y et al., Cell Death Dis 2021
RAB39B is a member of the Rab GTPase family involved in:
- Endolysosomal trafficking: Regulates vesicle movement
- Synaptic function: Important for neurotransmitter release
- Autophagy: Modulates autophagosome-lysosome fusion
- Neuronal development: Affects neurite outgrowth
As a small GTPase:
- Cycling between active (GTP-bound) and inactive (GDP-bound) states
- Requires GEFs for activation, GAPs for inactivation
- Effector proteins interact with active form
- Recycling between compartments
RAB39B interacts with:
- WASH complex (actin polymerization)
- Retromer complex (endosomal trafficking)
- Lysosomal proteins
- Synaptic vesicle proteins
RAB39B-associated PD:
- X-linked inheritance pattern
- Early-onset parkinsonism
- Often with intellectual disability
- Variable phenotype
Potential mechanisms:
- Endosomal trafficking defects
- Lysosomal dysfunction
- Synaptic protein mislocalization
- Mitochondrial involvement
| Approach |
Target |
Status |
| Gene therapy |
RAB39B expression |
Preclinical |
| Trafficking modulators |
Endolysosomal pathway |
Research |
| Neuroprotective agents |
Multiple targets |
Early development |
- Understanding RAB39B function in neurons
- Endosomal trafficking in PD
- Developing targeted therapies
- Genotype-phenotype correlations
The study of Rab39B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Macieszak A, et al. RAB39B mutations associated with Parkinson's disease. J Neurol Sci. 2016;369:271-277.
- Donatore A, et al. RAB39B and endosomal trafficking. Cell Mol Neurobiol. 2020;40(7):1055-1064.
- Gao Y, et al. RAB39B in synaptic function. J Neurosci Res. 2019;97(5):567-575.
The RAB39B protein contains several functional domains:
| Domain |
Position |
Function |
| GTP-binding domain |
N-terminus |
Nucleotide binding and hydrolysis |
| Switch I region |
Residues 35-50 |
Conformational change on GTP/GDP binding |
| Switch II region |
Residues 65-80 |
Interaction with effectors |
| Hypervariable region |
C-terminus |
Subcellular targeting |
| C-terminal cysteine motif |
C-terminus |
Geranylgeranylation for membrane association |
RAB39B mutations cause disease through several mechanisms:
- GTPase inactivation: Mutations in GTP-binding domain impair function
- Mislocalization: Mutations affect proper subcellular targeting
- Protein instability: Mutations lead to decreased protein levels
- Effector binding defects: Impaired interaction with downstream partners
RAB39B deficiency particularly affects dopaminergic neurons:
- Impaired autophagic flux leads to accumulation of damaged organelles
- Altered synaptic vesicle trafficking affects dopamine release
- Mitochondrial dysfunction increases oxidative stress
- Lysosomal impairment causes accumulation of α-synuclein
| Mutation |
Phenotype |
Severity |
| W71X (nonsense) |
Severe PD with ID |
Early onset, severe |
| G269R (missense) |
Moderate PD with ID |
Later onset |
| Splice site mutations |
Variable |
Dependent on splice effect |
| Whole gene deletion |
Severe |
Early onset |
- Rab39b knockout mice show:
- Age-dependent motor dysfunction
- Reduced striatal dopamine levels
- Accumulation of autophagic markers
- Loss of dopaminergic neurons in substantia nigra
- Patient-derived iPSC neurons demonstrate:
- Impaired neurite outgrowth
- Altered autophagy flux
- Mitochondrial dysfunction
- Increased sensitivity to oxidative stress
- Wilson GR, et al. (2014). RAB39B mutations cause X-linked PD. Am J Hum Genet 95: 729-735.
- Gong G, et al. (2019). RAB39B in endolysosomal trafficking. Autophagy 15: 1845-1862.
- Zhang Y, et al. (2021). RAB39B deficiency leads to neurodegeneration. Cell Death Dis 12: 234.
- Gene therapy: AAV-mediated RAB39B delivery to restore function
- Protein stabilization: Small molecules to enhance RAB39B stability
- Autophagy modulation: Enhancing clearance of RAB39B aggregates
- RAB39B expression in blood and CSF as potential PD biomarkers
- Genetic testing for RAB39B mutations in X-linked PD families
- Patient-derived iPSC neurons with RAB39B mutations
- Rab39b knockout mice showing dopaminergic neuron vulnerability